Aurantimycin A
Aurantimycin A (Adipogen), a depsipeptide antibiotic, displays strong activity against Gram-positive bacteria. Aurantimycin A is a substrate of the LieAB transporter[1][2].
Product Specifications
CAS Number
162478-50-4
UNSPSC
12352209
Target
Antibiotic; Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/aurantimycin-a.html
Solubility
10 mM in DMSO
Smiles
C[C@H]1[C@H](CC(C)C)CC[C@]([C@](C(N[C@H]2[C@H](C(C)C)OC([C@@H](C)N(O)C([C@@H]3CCCNN3C(CNC([C@H](COC)N(O)C([C@H]4CCCNN4C2=O)=O)=O)=O)=O)=O)=O)(O)C)(O)O1
Molecular Formula
C38H64N8O14
Molecular Weight
856.96
References & Citations
[1]U Gräfe, et al. Aurantimycins, new depsipeptide antibiotics from Streptomyces aurantiacus IMET 43917. Production, isolation, structure elucidation, and biological activity. J Antibiot (Tokyo) . 1995 Feb;48 (2) :119-25.|[2]Samuel Hauf, et al.Aurantimycin resistance genes contribute to survival of Listeria monocytogenes during life in the environment. Mol Microbiol. 2019 Apr;111 (4) :1009-1024.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog